| Product Code: ETC8329539 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Monaco Pharmacogenetic Testing Market Overview |
3.1 Monaco Country Macro Economic Indicators |
3.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Monaco Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Monaco Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Monaco Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Monaco Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growing awareness about the benefits of pharmacogenetic testing |
4.2.3 Rise in chronic diseases requiring personalized treatment |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited insurance coverage for pharmacogenetic testing |
4.3.3 Regulatory challenges in the healthcare industry |
5 Monaco Pharmacogenetic Testing Market Trends |
6 Monaco Pharmacogenetic Testing Market, By Types |
6.1 Monaco Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Monaco Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Monaco Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Monaco Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Monaco Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Monaco Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Monaco Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Monaco Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Monaco Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Monaco Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Monaco Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Monaco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Monaco Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Monaco Pharmacogenetic Testing Market Export to Major Countries |
7.2 Monaco Pharmacogenetic Testing Market Imports from Major Countries |
8 Monaco Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies supporting the efficacy of pharmacogenetic testing |
8.3 Patient satisfaction and outcomes post pharmacogenetic testing |
9 Monaco Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Monaco Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Monaco Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Monaco Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Monaco Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here